Pancreatic Cancer Research

ResearcherUniversità degli studi di Cassino e del Lazio MeridionaleActive in the last 2 years

Raffaéle Palaia

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-4299-3448; OpenAlex author ID A5053112027. Sources: OpenAlex.

Their work

Papers
21 (first author 3, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
26
Papers, trials and grants by year

2012: 2 papers · 2013: none · 2014: none · 2015: 2 papers · 2016: 4 papers · 2017: 2 papers · 2018: none · 2019: 1 paper · 2020: 3 papers · 2021: 3 papers · 2022: 2 papers · 2023: 1 paper · 2024: 1 paper

Papers 21

  1. The pan - COVID - AGICT study. The impact of COVID-19 pandemic on surgically treated pancreatic cancer patients. A multicentric Italian study. Co-author DOI 10.1016/j.suronc.2024.102081↗
  2. Risk Assessment and Pancreatic Cancer: Diagnostic Management and Artificial Intelligence. Co-author DOI 10.3390/cancers15020351↗
  3. Commentary: The Synergistic Role of Irreversible Electroporation and Chemotherapy for Locally Advanced Pancreatic Cancer. First author DOI 10.3389/fonc.2022.955444↗
  4. Comments on "The beneficial role of electrochemotherapy in locally advanced pancreatic cancer - radiological perspective". First author DOI 10.5114/pjr.2022.123567↗
  5. Pancreatic cancer detection and characterization: state of the art and radiomics. Co-author DOI 10.26355/eurrev_202105_25935↗
  6. Clinical Phase I/II Study: Local Disease Control and Survival in Locally Advanced Pancreatic Cancer Treated with Electrochemotherapy. Last author DOI 10.3390/jcm10061305↗
  7. A Multicenter Randomized Controlled Prospective Study to Assess Efficacy of Laparoscopic Electrochemotherapy in the Treatment of Locally Advanced Pancreatic Ca… Last author DOI 10.3390/jcm10174011↗
  8. Magnetic resonance imaging in the assessment of pancreatic cancer with quantitative parameter extraction by means of dynamic contrast-enhanced magnetic resonan… Co-author DOI 10.1177/1756284819885052↗
  9. Comments on "Electrochemotherapy with Irreversible Electroporation and FOLFIRINOX Improves Survival in Murine Models of Pancreatic Adenocarcinoma". Co-author DOI 10.1245/s10434-020-09183-1↗
  10. Assessment of Ablation Therapy in Pancreatic Cancer: The Radiologist's Challenge. Co-author DOI 10.3389/fonc.2020.560952↗
  11. Diffusion kurtosis imaging and conventional diffusion weighted imaging to assess electrochemotherapy response in locally advanced pancreatic cancer. Co-author DOI 10.2478/raon-2019-0004↗
  12. An overview of pre-clinical studies on the effects of (-)-epigallocatechin-3-gallate, a catechin found in green tea, in treatment of pancreatic cancer Co-author DOI 10.1701/2715.27715↗
  13. Early radiological assessment of locally advanced pancreatic cancer treated with electrochemotherapy. Co-author DOI 10.3748/wjg.v23.i26.4767↗
  14. The Role of miRNAs in the Regulation of Pancreatic Cancer Stem Cells. Co-author DOI 10.1155/2016/8352684↗
  15. Multidetector computer tomography in the pancreatic adenocarcinoma assessment: an update. Co-author DOI 10.1186/s13027-016-0105-6↗
  16. Electrochemotherapy in pancreatic adenocarcinoma treatment: pre-clinical and clinical studies. Co-author DOI 10.1515/raon-2016-0003↗
  17. Curcumin AntiCancer Studies in Pancreatic Cancer. Co-author DOI 10.3390/nu8070433↗
  18. Electrochemotherapy in locally advanced pancreatic cancer: Preliminary results. Co-author DOI 10.1016/j.ijsu.2015.04.055↗
  19. Electrochemotherapy as a new approach on pancreatic cancer and on liver metastases. Co-author DOI 10.1016/j.ijsu.2015.04.095↗
  20. Expression of the antiapoptotic protein BAG3 is a feature of pancreatic adenocarcinoma and its overexpression is associated with poorer survival. Co-author DOI 10.1016/j.ajpath.2012.07.016↗
  21. Is preoperative endoscopic biliary drainage indicated for jaundiced patients with resectable pancreatic cancer? First author DOI 10.2174/138945012800564167↗

Closest collaborators

The 25 strongest of 26 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Vincenza Granata · 17 shared papers, 2015–2023 · strength 1.84
  2. Francesco Izzo · 17 shared papers, 2015–2023 · strength 1.79
  3. Antonella Petrillo · 14 shared papers, 2015–2023 · strength 1.26
  4. Antonio Avallone · 4 shared papers, 2020–2023 · strength 0.47
  5. Sabrina Bimonte · 4 shared papers, 2016–2017 · strength 0.23
  6. Luca Brunese · 2 shared papers, 2020–2021 · strength 0.23
  7. Mario De Bellis · 2 shared papers, 2012–2023 · strength 0.18
  8. Salvatore Tafuto · 2 shared papers, 2015–2021 · strength 0.16
  9. Steven A. Curley · 1 shared paper, 2020 · strength 0.10
  10. Arturo Cuomo · 1 shared paper, 2017 · strength 0.08
  11. Francesco Fiore · 1 shared paper, 2012 · strength 0.04
  12. Alessandra Rosati · 1 shared paper, 2012 · strength 0.02
  13. Elisa Dalla Pozza · 1 shared paper, 2012 · strength 0.02
  14. Fabio F. di Mola · 1 shared paper, 2012 · strength 0.02
  15. Marta Palmieri · 1 shared paper, 2012 · strength 0.02
  16. Ilaria Dando · 1 shared paper, 2012 · strength 0.02
  17. Andrea Fontana · 1 shared paper, 2012 · strength 0.02
  18. Vincenzo De Laurenzi · 1 shared paper, 2012 · strength 0.02
  19. Maria Caterina Turco · 1 shared paper, 2012 · strength 0.02
  20. Pierluigi Di Sebastiano · 1 shared paper, 2012 · strength 0.02
  21. Frederike Dijk · 1 shared paper, 2012 · strength 0.02
  22. Margot De Marco · 1 shared paper, 2012 · strength 0.02
  23. Francesca Tavano · 1 shared paper, 2012 · strength 0.02
  24. Raffaele Pezzilli · 1 shared paper, 2012 · strength 0.02
  25. Massimo Donadelli · 1 shared paper, 2012 · strength 0.02

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.